October Pharma S.A.E (EGX:OCPH)
Egypt
· Delayed Price · Currency is EGP 200.61
-8.65 (-4.13%)
At close: Dec 4, 2025
October Pharma S.A.E Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 2,407 | 1,310 | 1,200 | 1,200 | 978 | 600 | Upgrade
|
| Market Cap Growth | 74.37% | 9.14% | - | 22.68% | 63.02% | 51.52% | Upgrade
|
| Enterprise Value | 2,754 | 1,817 | 1,518 | 1,257 | 1,193 | 853 | Upgrade
|
| Last Close Price | 200.61 | 109.14 | 97.50 | 97.50 | 77.49 | 46.11 | Upgrade
|
| PE Ratio | 17.04 | 9.98 | 7.98 | 10.55 | 8.16 | 6.80 | Upgrade
|
| PS Ratio | 1.70 | 1.07 | 1.19 | 1.65 | 1.49 | 1.10 | Upgrade
|
| PB Ratio | 3.75 | 2.30 | 2.04 | 2.82 | 2.88 | 2.36 | Upgrade
|
| P/TBV Ratio | 4.28 | 2.68 | 2.41 | 3.67 | 4.18 | 4.25 | Upgrade
|
| P/FCF Ratio | 7.78 | - | 10.17 | - | 4.04 | 12.59 | Upgrade
|
| P/OCF Ratio | 7.24 | 30.29 | 7.83 | - | 3.73 | 11.26 | Upgrade
|
| EV/Sales Ratio | 1.95 | 1.48 | 1.50 | 1.73 | 1.82 | 1.57 | Upgrade
|
| EV/EBITDA Ratio | 6.85 | 5.19 | 4.61 | 5.68 | 5.52 | 5.20 | Upgrade
|
| EV/EBIT Ratio | 7.54 | 5.67 | 4.94 | 6.31 | 6.10 | 5.88 | Upgrade
|
| EV/FCF Ratio | 8.91 | - | 12.87 | - | 4.92 | 17.90 | Upgrade
|
| Debt / Equity Ratio | 0.75 | 0.97 | 0.55 | 0.76 | 0.22 | 0.98 | Upgrade
|
| Debt / EBITDA Ratio | 1.19 | 1.57 | 0.98 | 1.46 | 0.34 | 1.52 | Upgrade
|
| Debt / FCF Ratio | 1.55 | - | 2.75 | - | 0.31 | 5.21 | Upgrade
|
| Asset Turnover | 1.04 | 0.96 | 0.97 | 0.97 | 1.13 | 0.95 | Upgrade
|
| Inventory Turnover | 2.56 | 2.89 | 2.45 | 1.78 | 2.15 | 2.55 | Upgrade
|
| Quick Ratio | 0.48 | 0.39 | 0.56 | 0.36 | 0.75 | 0.31 | Upgrade
|
| Current Ratio | 1.62 | 1.44 | 1.82 | 1.54 | 2.17 | 1.38 | Upgrade
|
| Return on Equity (ROE) | 25.76% | 26.20% | 35.89% | 34.18% | 40.38% | 40.64% | Upgrade
|
| Return on Assets (ROA) | 16.81% | 15.70% | 18.38% | 16.57% | 21.09% | 15.84% | Upgrade
|
| Return on Capital (ROIC) | 20.09% | 19.69% | 23.10% | 21.43% | 26.69% | 19.29% | Upgrade
|
| Return on Capital Employed (ROCE) | 48.90% | 47.00% | 45.10% | 37.90% | 48.80% | 44.50% | Upgrade
|
| Earnings Yield | 5.87% | 11.59% | 15.18% | 10.90% | 12.25% | 14.71% | Upgrade
|
| FCF Yield | 12.85% | -0.75% | 9.83% | -15.42% | 24.79% | 7.94% | Upgrade
|
| Dividend Yield | - | - | 2.56% | - | - | 3.25% | Upgrade
|
| Payout Ratio | 12.60% | 36.54% | 9.86% | 34.16% | 28.54% | 16.83% | Upgrade
|
| Total Shareholder Return | - | - | 2.56% | - | - | 3.25% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.